New insights into the mechanism of acquired resistance to KRAS G12C inhibitors
Lung and other thoracic tumours

New insights into the mechanism of acquired resistance to KRAS G12C inhibitors

Sequencing data suggest that non-G12C KRAS mutations could mediate intrinsic resistance to treatments in non-small-cell lung cancer, but functional confirmation is required 

Read more

Don't miss

  • Keynote lecture
    8 November 2021, 13:45-14:15, Channel 1
  • Mini-Oral session
    8 November 2021, 16:00-17:00, Channel 1
  • Gordon Peters lecture
    9 November 2021, 13:45-14:15, Channel 1

PRECISION ONCOLOGY

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings